See All Slides - tctmd.com

Slides

Presentation CTO 2015

Performing and Evaluating the Angiogram

Presenter: Jeffrey W. Moses, Gerald S. Werner, Hisayuki Okada

February 26, 2015

Presentation CTO 2015

Case Selection: Indications for CTO-PCI

Presenter: Jeffrey W. Moses, Gerald S. Werner, James C. Spratt

February 26, 2015

Presentation

Association Between Hospital Guideline Adherence, Dosing Safety, and Outcomes Among ACS Patients

Presenter: Rajendra H. Mehta

February 25, 2015

Presentation

Trends in Endovascular Therapy and Clinical Outcomes

Presenter: Bijoy K. Menon

February 24, 2015

Presentation

Rupture Rates of Untreated Large AAAs in Patients Unfit for Elective Repair

Presenter: F. Parkinson

February 24, 2015

Presentation

Zotarolimus-Eluting vs Bare-Metal Stents in Uncertain DES Candidates

Presenter: Marco Valgimigli

February 23, 2015

Presentation

Association of NSAID Use with Risk of Bleeding, CV Events in Patients Receiving Antithrombotic Therapy After MI

Presenter: Anne-Marie Schjerning Olsen

February 23, 2015

Presentation

Occupational Health Hazards of Working in the Interventional Laboratory

Presenter: N.M. Orme

February 22, 2015

Presentation

Randomized Phase 2 Trial of Intracoronary Nitrite During Acute MI

Presenter: D.A. Jones

February 22, 2015

Presentation CADECI 2015

Uso responsable de Rivaroxabán en prevención secundaria después de un SCA:Casos clínicos_

Presenter: DR. JOSE LUIS LEIVA PONS

February 20, 2015

Advertisement

Slides

Performing and Evaluating the Angiogram

Case Selection: Indications for CTO-PCI

Association Between Hospital Guideline Adherence, Dosing Safety, and Outcomes Among ACS Patients

Trends in Endovascular Therapy and Clinical Outcomes

Rupture Rates of Untreated Large AAAs in Patients Unfit for Elective Repair

Zotarolimus-Eluting vs Bare-Metal Stents in Uncertain DES Candidates

Association of NSAID Use with Risk of Bleeding, CV Events in Patients Receiving Antithrombotic Therapy After MI

Occupational Health Hazards of Working in the Interventional Laboratory

Randomized Phase 2 Trial of Intracoronary Nitrite During Acute MI

Uso responsable de Rivaroxabán en prevención secundaria después de un SCA:Casos clínicos_

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content